START YOUNG is a groundbreaking, investigator-initiated, prospective, multicenter, randomized trial comparing surgical aortic valve replacement (SAVR) and transcatheter aortic valve replacement (TAVR) using the balloon-expandable Myval THV in patients aged 65 to 75 years with symptomatic severe...
The Strength study aim to evaluate the use of the RenalGuard device to protect the patients at high risk to develop acute kidney injury following a complex cardiovascular intervention requiring a high volume of contrast. ID: NCT02793661
Single-arm, Prospective, Open label, All Comers, Multicenter Registry. The objective is to collect and evaluate clinical data regarding the safety and performance of the Support C in a real-world setting (in clinical routine)
The SYNC Study: Pivotal Clinical Study of VDI’s Ultra-High FrequencY Electrocardiogram (UHF-ECG) for the DiagNosis of VentriCular Electrical Dyssynchrony (VED) The VDI Ultra-High Frequency (UHF) ECG System is intended to aid in the detection of Ventricular Electrical Dyssynchrony (VED) in patients...
TACTIC is a prospective, multi-center, randomized 1:1, controlled, open label, study. The objective of the study is to evaluate the impact of sustained thrombectomy versus no thrombectomy during primary percutaneous coronary intervention (PPCI) on microvascular obstruction and infarct size, as...
Cardiovalve proposes a non-invasive, simply deployed, transferal expandable bioprosthetic valve for eliminating tricuspid regurgitation in patients who are not suitable for open heart surgery. Cardiovalve targets an unmet clinical need. TARGET study is a prospective, single arm, open label, multi...
TARGET FIRST is a prospective, international, multicentre, open-label, randomized (1:1) post-market study to evaluate a modified Anti-Platelet Therapy associated with low-dose rapamycin DES Firehawk in Acute Myocardial Infarction Patients treated with complete revascularization strategy. The...
The THRIVE study is a pivotal, prospective, multicenter, 2:1 randomized, double blind, controlled, study. The objective is to compare the THerapeutic IntravasculaR Ultrasound (TIVUS ) REnal Denervation System vs. Sham for the Adjunctive Treatment of Hypertension.
Tranform II is an investigator-drive prospective, multicentric, international, randomized clinical trial. The objective is to observe and evaluate the efficacy of Magic Touch SCB compared to the gold standard treatment for native vessel disease, namely new-generation everolimus-eluting DES. The...
Aprospective, single-arm, multi-center, observational, post-market clinical follow-up study, aimed to assess the safety and effectiveness/performance of the self-expanding VitaFlow Liberty™ Transcatheter Aortic Valve System in symptomatic patients with severe aortic stenosis in the post market use...
